CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 164 filers reported holding CLOVIS ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $20,000 | -72.6% | 16,700 | -58.6% | 0.00% | – |
| Q2 2022 | $73,000 | -85.9% | 40,358 | -84.2% | 0.00% | -100.0% |
| Q1 2022 | $517,000 | +205.9% | 255,741 | +309.2% | 0.00% | – |
| Q4 2021 | $169,000 | -74.9% | 62,496 | -58.6% | 0.00% | -100.0% |
| Q3 2021 | $674,000 | -19.9% | 151,091 | +4.2% | 0.00% | -33.3% |
| Q2 2021 | $841,000 | +68.9% | 145,069 | +104.6% | 0.00% | 0.0% |
| Q1 2021 | $498,000 | -8.1% | 70,921 | -37.2% | 0.00% | -25.0% |
| Q4 2020 | $542,000 | +94.3% | 112,857 | +157.0% | 0.00% | -42.9% |
| Q1 2020 | $279,000 | -64.7% | 43,908 | -42.0% | 0.01% | +40.0% |
| Q4 2019 | $790,000 | -31.4% | 75,735 | -74.1% | 0.01% | -50.0% |
| Q3 2019 | $1,151,000 | +89.0% | 292,844 | +614.9% | 0.01% | +66.7% |
| Q2 2019 | $609,000 | -20.6% | 40,963 | +32.5% | 0.01% | -25.0% |
| Q1 2019 | $767,000 | -45.9% | 30,919 | -60.9% | 0.01% | -52.9% |
| Q4 2018 | $1,419,000 | +602.5% | 78,985 | +1049.9% | 0.02% | +750.0% |
| Q3 2018 | $202,000 | -89.0% | 6,869 | -83.0% | 0.00% | -91.7% |
| Q2 2018 | $1,834,000 | +460.9% | 40,336 | +550.6% | 0.02% | +380.0% |
| Q1 2018 | $327,000 | -54.2% | 6,200 | -40.9% | 0.01% | -58.3% |
| Q4 2017 | $714,000 | +182.2% | 10,493 | +288.6% | 0.01% | +140.0% |
| Q2 2017 | $253,000 | -72.6% | 2,700 | -87.0% | 0.01% | -86.8% |
| Q4 2016 | $925,000 | +267.1% | 20,813 | +197.3% | 0.04% | +123.5% |
| Q3 2016 | $252,000 | -55.0% | 7,000 | -56.2% | 0.02% | -72.1% |
| Q4 2015 | $560,000 | – | 16,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |